Evidence map›Paper›PMID 38026761›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Remote and in-clinic digital cognitive screening tools outperform the MoCA to distinguish cerebral amyloid status among cognitively healthy older adults.

Louisa I Thompson, Zachary J Kunicki, Sheina Emrani, Jennifer Strenger, Alyssa N De Vito, Karysa J Britton, Catherine Dion, Karra D Harrington, Nelson Roque, Stephen Salloway and 3 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Tablet-based Cognitive Assessment Tool (TabCAT) in a multisite study of early-onset Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  14. Detecting Alzheimer's disease using digital virtual reality cognitive tests.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Louisa I ThompsonDepartment of Psychiatry & Human Behavior Alpert Medical School Brown University Providence Rhode Island USA.ORCID https://orcid.org/0000-0002-7231-870X
Zachary J KunickiDepartment of Psychiatry & Human Behavior Alpert Medical School Brown University Providence Rhode Island USA.ORCID https://orcid.org/0000-0002-3466-7589
Sheina EmraniDepartment of Psychiatry & Human Behavior Alpert Medical School Brown University Providence Rhode Island USA.ORCID https://orcid.org/0000-0002-1235-5285
Jennifer StrengerDepartment of Psychiatry & Human Behavior Alpert Medical School Brown University Providence Rhode Island USA.
Alyssa N De VitoDepartment of Psychiatry & Human Behavior Alpert Medical School Brown University Providence Rhode Island USA.ORCID https://orcid.org/0000-0002-4078-3869
Karysa J BrittonMemory & Aging Program Butler Hospital Providence Rhode Island USA.
Catherine DionDepartment of Clinical and Health Psychology University of Florida Gainesville Florida USA.ORCID https://orcid.org/0000-0003-3153-7858
Karra D HarringtonDepartment of Human Development & Family Studies The Pennsylvania State University University Park Pennsylvania USA.ORCID https://orcid.org/0000-0001-9230-2978
Nelson RoqueDepartment of Psychology University of Central Florida Orlando Florida USA.
Stephen SallowayDepartment of Psychiatry & Human Behavior Alpert Medical School Brown University Providence Rhode Island USA.
Martin J SliwinskiDepartment of Human Development & Family Studies The Pennsylvania State University University Park Pennsylvania USA.
Stephen CorreiaDepartment of Health Promotion and Behavior School of Public Health University of Georgia Florida USA.ORCID https://orcid.org/0000-0003-3416-3660
Richard N JonesDepartment of Psychiatry & Human Behavior Alpert Medical School Brown University Providence Rhode Island USA.ORCID https://orcid.org/0000-0002-1049-218X
Brown University · USPennsylvania State University · USProvidence College · USUniversity of Central Florida · USUniversity of Florida Health · USUniversity of Georgia · US

Funding

Ambulatory Methods for Measuring Cognitive ChangeU2CAG060408 · NIA · PENNSYLVANIA STATE UNIVERSITY, THE · PI SLIWINSKI, MARTIN J · 2018 to 2022
$14.9M
Psychosocial Determinants and Biological Pathway to Healthy Aging (Pathways)T32AG049676 · NIA · PENNSYLVANIA STATE UNIVERSITY, THE · PI LYNN M. MARTIRE · 2016 to 2026
$3.9M
NIA NIH HHS T32 AG049676NIA NIH HHS U2C AG060408
6 · The paper itself

Abstract

introductionWe evaluated the accuracy of remote and in-person digital tests to distinguish between older adults with and without AD pathological change and used the Montreal Cognitive Assessment (MoCA) as a comparison test.

methodsParticipants were 69 cognitively normal older adults with known beta-amyloid (Aβ) PET status. Participants completed smartphone-based assessments 3×/day for 8 days, followed by TabCAT tasks, DCTclock™, and MoCA at an in-person study visit. We calculated the area under the curve (AUC) to compare task accuracies to distinguish Aβ status.

resultsAverage performance on the episodic memory (Prices) smartphone task showed the highest accuracy (AUC = 0.77) to distinguish Aβ status. On in-person measures, accuracy to distinguish Aβ status was greatest for the TabCAT Favorites task (AUC = 0.76), relative to the DCTclock DISCUSSION: Although further validation is needed, our results suggest that several digital assessments may be suitable for more widespread cognitive screening application.

Indexed as

cognitive screeningdigital technologyearly diagnosispreclinical Alzheimer's disease

Identifiers

PMID38026761
PMCPMC10680059
OpenAlexW4389037728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.